Welcome to LookChem.com Sign In|Join Free

CAS

  • or

125-29-1

Post Buying Request

125-29-1 Suppliers

Recommended suppliersmore

This product is a nationally controlled contraband, and the Lookchem platform doesn't provide relevant sales information.

125-29-1 Usage

Description

Hydrocodone is a semi-synthetic opioid derived from codeine, chemically classified as a morphinane-like compound. It is a beige solid with potent agonist activity that does not require 3-O-demethylation, although it can occur via CYP2D6. The 3-position protection and the 7,8-dihydro-6-keto C ring contribute to its increased binding to the μ-receptor, making it a powerful analgesic and antitussive agent. Hydrocodone is approximately 4 to 5 times less potent than hydromorphone, which is about equal to morphine. It is a controlled substance and falls under the category of narcotics.

Uses

1. Used in Pharmaceutical Industry:
Hydrocodone is used as an analgesic (narcotic) for the treatment of moderate to severe pain. It is combined with other medications such as acetaminophen (Vicodin, Lortab) or aspirin (Lortab ASA) to enhance its pain-relieving effects.
2. Used in Cough Suppressants:
Hydrocodone is used as an antitussive to suppress the cough reflex. It is widely used in commercial anticough drugs in combination with various agents such as guaifenesin (entuss), homatropine (hycodan), phenylpropanolamine (hycomine), phenyltoloxamine (tussionex), and pseudoephedrine and guaiphenesin (tussened).
3. Used in Antitussive Agents:
Hydrocodone is marketed as an antitussive agent, available in combination with the anticholinergic agent homatropine as a syrup and a tablet. The addition of the anticholinergic agent aims to discourage abuse.
4. Used in Delayed Release Suspension Form:
Hydrocodone is available in a delayed-release suspension form (Tussionex), which uses a sulfonated styrene divinylbenzene copolymer complexed with hydromorphone and chlorpheniramine that acts as a cation-exchange resin, slowly releasing the drugs over a 12-hour period.

Originator

Dicodid,Knoll,Belgium

Manufacturing Process

60 g of codeine about 94.5% (anhydrous codeine alkaloid basis) was dissolved in a solution made from 10 ml concentrated sulfuric acid and 390 ml water The mixture was refluxed for one hour with 25.0 g of 5% Pd on charcoal. The hot solution was immediately filtered and the catalyst was washed with 400 ml of dilute sulfuric acid of the same strength as was used in the rearrangement described above. To the combined cooled filtrate and wash, 750 ml if benzene was added, after which the mixture was cooled to 15°C, stirred, and made alkaline to pH 10 by addition of 80 ml of 40% NaOH. After shaking and separating the aqueous layer was extracted twice with 500 ml benzene. The combined benzene extracts are then extracted three times with 500 ml and twice with 400 ml portions of fresh 10% sodium bisulfite solution. Crude dihydrocodeinone was precipitated from bisulfite solution by eddition of 180 ml 40% NaOH at 15°C (to pH 10). The product was filtered, washed well and air-dried at room temperature. The melting point was about 184°C and yield about 35-38 g or 58-59%. The product was darken and the rest of Pd on charcoal and the original alkaloid were removed with column of Al2O3 (eluent - dry ethylene chloride) to give the dihyrocodeinone.

Therapeutic Function

Narcotic analgesic, Antitussive

Safety Profile

Poison by intravenous and subcutaneous routes. When heated to decomposition it emits toxic fumes of NOx.

Check Digit Verification of cas no

The CAS Registry Mumber 125-29-1 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 1,2 and 5 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 125-29:
(5*1)+(4*2)+(3*5)+(2*2)+(1*9)=41
41 % 10 = 1
So 125-29-1 is a valid CAS Registry Number.
InChI:InChI=1/C18H21NO3/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19/h3,6,11-12,17H,4-5,7-9H2,1-2H3/t11-,12+,17-,18-/m0/s1

125-29-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name hydrocodone

1.2 Other means of identification

Product number -
Other names Bekadid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:125-29-1 SDS

125-29-1Related news

Anomalous observations of HYDROCODONE (cas 125-29-1) in patients on oxycodone09/28/2019

BackgroundUrine drug monitoring is used by physicians treating chronic pain patients with opioid therapy. Patients are tested in part to insure that they are not taking other drugs. Therefore, the finding of hydrocodone in a patient who is only prescribed oxycodone has clinical implications. Oxy...detailed

Acetaminophen modulation of HYDROCODONE (cas 125-29-1) reward in rats10/01/2019

Abuse of prescription opioid analgesics in non-medical context has been on the rise over the past decade. The most commonly abused analgesic in this drug class consists of a combined formulation of hydrocodone and acetaminophen. The present study was aimed to determine the rewarding effects of h...detailed

HYDROCODONE (cas 125-29-1) in postoperative personalized pain management: Pro-drug or drug?09/27/2019

BackgroundGenetic variations in enzymes that produce active metabolites from pro-drugs are well known. Such variability could account for some of the clinically observed differences in analgesia and side effects seen in postoperative patients. Using genotyping and quantitation of serum concentra...detailed

Effects of Paroxetine, a CYP2D6 Inhibitor, on the Pharmacokinetic Properties of HYDROCODONE (cas 125-29-1) After Coadministration With a Single-entity, Once-daily, Extended-release HYDROCODONE (cas 125-29-1) Tablet09/26/2019

PurposeA single-entity, once-daily, extended-release formulation of hydrocodone bitartrate (HYD) has been developed for the management of moderate to severe chronic pain. Hydrocodone undergoes cytochrome P-450 (CYP)-mediated metabolism involving the CYP3A4 and CYP2D6 isozymes. CYP3A4 yields norh...detailed

Effects of ceftriaxone on HYDROCODONE (cas 125-29-1) seeking behavior and glial glutamate transporters in P rats09/25/2019

Hydrocodone (HYD) is one of the most widely prescribed opioid analgesic drugs. Several neurotransmitters are involved in opioids relapse. Among these neurotransmitters, glutamate is suggested to be involved in opioid dependence and relapse. Glutamate is regulated by several glutamate transporter...detailed

Selected Topics: ToxicologyComparison of Unintentional Exposures to Codeine and HYDROCODONE (cas 125-29-1) Reported to Texas Poison Centers09/24/2019

BackgroundHydrocodone has recently been reclassified as a Schedule II drug by the United States Drug Enforcement Administration and Food and Drug Administration in order to curtail prescription drug abuse. There is concern that analgesic substitutes, such as codeine, will not be as safe or effec...detailed

Postoperative opioid prescribing practices and the impact of the HYDROCODONE (cas 125-29-1) schedule change09/10/2019

BackgroundIn 2014, hydrocodone was moved from Schedule III to II, thus it could no longer be “called in” to a pharmacy. We analyzed current postoperative opioid prescribing patterns and the impact of the schedule change on the type and amount prescribed.detailed

Short CommunicationPharmacokinetics of HYDROCODONE (cas 125-29-1) and hydromorphone after oral HYDROCODONE (cas 125-29-1) in healthy Greyhound dogs09/09/2019

The purpose of this study was to determine the pharmacokinetics of hydrocodone and its active metabolite hydromorphone in six healthy Greyhound dogs. Hydrocodone bitartrate was administered at a targeted dose of 0.5 mg/kg PO. Plasma concentrations of hydrocodone and hydromorphone were determined...detailed

Research reportReversal of oxycodone and HYDROCODONE (cas 125-29-1) tolerance by diazepam09/08/2019

The Centers for Disease Control has declared opioid abuse to be an epidemic. Overdose deaths are largely assumed to be the result of excessive opioid consumption. In many of these cases, however, opioid abusers are often polydrug abusers. Benzodiazepines are one of the most commonly co-abused su...detailed

125-29-1Relevant articles and documents

Studies on regioselective hydrogenation of thebaine and its conversion to hydrocodone

Leisch, Hannes,Carroll, Robert J.,Hudlicky, Tomas,Cox, D. Phillip

, p. 3979 - 3981 (2007)

Thebaine was subjected to catalytic hydrogenation under a variety of conditions in order to determine the regioselectivity for C-6/C-7 versus C-8/C-14 olefin saturation.

-

Carroll,F.I. et al.

, p. 996 - 1001 (1976)

-

14,17-Cyclonorcodeinone dimethylacetal: A New Codeinon Derivative, II

Fleischhacker, W.,Richter, B.,Voellenkle, H.

, p. 399 - 411 (1991)

In addition to a short communication describing the synthesis of 14,17-cyclonorcodeinone dimethylacetal 1a we wish to present a simple alternative route together with a selection of some reactions depending on the great reactivity of this highly strained small ring system.The structure of 1a is established by X-ray analysis.

Transition metal-catalyzed redox isomerization of codeine and morphine in water

Gomez, Antonio Bermejo,Holmberg, Paer,Baeckvall, Jan-E.,Martin-Matute, Belen

, p. 39519 - 39522 (2014)

A water-soluble rhodium complex formed from commercially available [Rh(COD)(CH3CN)2]BF4 and 1,3,5-triaza-7- phosphaadamantane (PTA) catalyzes the isomerization of both codeine and morphine into hydrocodone and hydromorphone with very high efficiency. The reaction is performed in water, allowing isolation of the final products by simple filtration, which results in very high isolated yields. The reactions can be easily scaled up to 100 g.

PROCESS FOR THE PREPARATION OF BENZHYDROCODONE HYDROCHLORIDE

-

Paragraph 0190-0191, (2018/03/25)

The invention is directed to processes for the preparation of benzhydrocodone hydrochloride. More particularly, the invention is directed to processes for a one-pot synthesis of benzhydrocodone hydrochloride of improved yield and/or purity.

General, Simple, and Chemoselective Catalysts for the Isomerization of Allylic Alcohols: The Importance of the Halide Ligand

Erbing, Elis,Vázquez-Romero, Ana,Bermejo Gómez, Antonio,Platero-Prats, Ana E.,Carson, Fabian,Zou, Xiaodong,Tolstoy, P?ivi,Martín-Matute, Belén

supporting information, p. 15659 - 15663 (2016/10/25)

Remarkably simple IrIIIcatalysts enable the isomerization of primary and sec-allylic alcohols under very mild reaction conditions. X-ray absorption spectroscopy (XAS) and mass spectrometry (MS) studies indicate that the catalysts, with the general formula [Cp*IrIII], require a halide ligand for catalytic activity, but no additives or additional ligands are needed.